Image
This training session defines the latest in antiretroviral therapy with regard to when and what to start. It also discusses reasons for modifying therapy along with current strategies for those who are virologically suppressed with and without underlying drug-resistant virus, as well as those experiencing virologic failure. A brief overview is also provided regarding emerging treatment strategies that may be available in the near future.
Speaker
Eric S. Daar, M.D.
Chief, Division of HIV Medicine
Harbor-UCLA Medical Center
Investigator, Lundquist Institute
Professor of Medicine
David Geffen School of Medicine at UCLA
No accreditation for recorded or archived events.
Browse more